Neuro-Oncological Ventral Antigen 1 (NOVA1) (Middle Region) Peptide
NOVA1
Reactivity: Human
Host: Synthetic
BP, WB
Quick Overview for Neuro-Oncological Ventral Antigen 1 (NOVA1) (Middle Region) Peptide (ABIN980818)
Target
NOVA1
(Neuro-Oncological Ventral Antigen 1 (NOVA1))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-NOVA1 antibody (Catalog #: ARP40398_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
Neuro-Oncological Ventral Antigen 1 (NOVA1) peptide
NOVA1 Reactivity: Human Host: Synthetic BP, Imm
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
-
Background
-
NOVA1 is a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies. These antibodies are found in the sera of patients with paraneoplastic opsoclonus-ataxia, breast cancer, and small cell lung cancer. This gene encodes a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies. These antibodies are found in the sera of patients with paraneoplastic opsoclonus-ataxia, breast cancer, and small cell lung cancer. Alternatively spliced transcripts encoding distinct isoforms have been described.
Alias Symbols: Nova-1
Protein Interaction Partner: NOVA1,PCBP1,SMARCC2
Protein Size: 507 -
Molecular Weight
- 52 kDa
-
Gene ID
- 4857
-
NCBI Accession
- NM_002515, NP_002506
-
UniProt
- A8K603
Target
-
You are here:
